New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
07:31 EDTTHORThoratec long-term opportunity remains intact, says Leerink
Leerink believes Thoratec's long-term market opportunity remains intact despite the company's disappointing Q2 results. The firm reiterates an Outperform rating on the stock, but notes shares are likely to be range-bound in the near-term. Leerink lowered it s price target for the name to $35 from $40. Thoratec was downgraded this morning at Credit Suisse and Goldman Sachs.
News For THOR From The Last 14 Days
Check below for free stories on THOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 22, 2014
07:35 EDTTHORThoratec sees Q3 revenue $102M-$107M, consensus $109.54M
Subscribe for More Information
07:34 EDTTHORThoratec appoints Keith Grossman President and CEO
Subscribe for More Information
September 17, 2014
11:41 EDTTHORLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use